AB Cotspin IPO vs Fabino Life Sciences IPO

Comparison between AB Cotspin IPO and Fabino Life Sciences IPO.

IPO Details

AB Cotspin IPO is a SME Fixed Price IPO proposed to list at NSE SME while Fabino Life Sciences IPO is a SME Fixed Price proposed to list at BSE SME.

Issue Size and Price

The total issue size of AB Cotspin IPO is up to ₹9.58 Cr whereas the issue size of the Fabino Life Sciences IPO is up to ₹3.07 Cr. The final issue price of AB Cotspin IPO is ₹35.00 per share and of Fabino Life Sciences IPO is ₹36.00 per share.

 AB Cotspin IPOFabino Life Sciences IPO
Face Value₹10 per share₹10 per share
Issue Price (Lower)₹33.00 per share
Issue Price (Upper)₹35.00 per share
Issue Price (Final)₹35.00 per share₹36.00 per share
Discount (Retail)₹0.00 per share₹0.00 per share
Market Lot Size4000 shares3000 shares
Fresh Issue Size27,36,000 shares8,52,000 shares
Fresh Issue Size (Amount)up to ₹9.58 Crup to ₹3.07 Cr
OFS Issue Size0 shares0 shares
OFS Issue Size (Amount)up to ₹0.00 Crup to ₹0.00 Cr
Issue Size Total27,36,000 shares8,52,000 shares
Issue Size Total (Amount)up to ₹9.58 Crup to ₹3.07 Cr

IPO Timetable

AB Cotspin IPO opens on Dec 30, 2021, while Fabino Life Sciences IPO opens on Dec 31, 2021. The closing date of AB Cotspin IPO and Fabino Life Sciences IPO is Jan 03, 2022, and Jan 05, 2022, respectively.

 AB Cotspin IPOFabino Life Sciences IPO
Issue OpenDec 30, 2021Dec 31, 2021
Issue CloseJan 03, 2022Jan 05, 2022
Basis Of Allotment (Tentative)Jan 06, 2022Jan 10, 2022
Initiation of Refunds (Tentative)Jan 07, 2022Jan 11, 2022
Credit of Share (Tentative)Jan 10, 2022Jan 12, 2022
Listing date (Tentative)Jan 11, 2022Jan 13, 2022

Financials & KPIs

AB Cotspin IPO P/E ratio is 2.71, as compared to Fabino Life Sciences IPO P/E ratio of 133.

 AB Cotspin IPOFabino Life Sciences IPO
Financials

Company Financials (Restated)

Period Ended30 Jun 202131 Mar 202131 Mar 202031 Mar 2019
Assets71.8463.7052.7655.05
Total Income30.53115.5794.28121.06
Profit After Tax3.323.880.761.33
EBITDA5.7410.105.677.61
NET Worth25.2221.8317.9517.21
Reserves and Surplus17.6219.1715.2914.55
Total Borrowing38.7636.0829.1133.93
Amount in ₹ Crore

Company Financials (Restated)

Period Ended30 Jun 202131 Mar 202131 Mar 202031 Mar 2019
Assets2.812.253.598.55
Total Income1.133.067.522.76
Profit After Tax0.010.030.070.00
EBITDA0.030.060.320.32
NET Worth1.321.300.670.60
Reserves and Surplus0.120.100.520.45
Total Borrowing0.420.311.082.52
Amount in ₹ Crore
Promoter Shareholding (Pre-Issue)48.5%99.43%
Promoter Shareholding (Post-Issue)34.91%56.82%
P/E Ratio2.71133
Market Cap₹36.02 Cr.₹7.56 Cr.

Shares Offered

In the AB Cotspin IPO Retail Individual Investors (RII) are offered 13,68,000 shares while in Fabino Life Sciences IPO retail investors are offered 13,68,000 shares. Qualified Institutional Buyers (QIB) are offered in AB Cotspin IPO and in Fabino Life Sciences IPO.

 AB Cotspin IPOFabino Life Sciences IPO
Market Maker Reservation1,48,000 shares48,000 shares
NII13,68,000 shares4,26,000 shares
RII13,68,000 shares4,26,000 shares
Total27,36,000 shares8,52,000 shares

Bids Received (Subscription)

AB Cotspin IPO subscribed 13.46x in total, whereas Fabino Life Sciences IPO subscribed 6.93x.

 AB Cotspin IPOFabino Life Sciences IPO
NII (times)9.45x3.49x
RII (times)17.47x10.36x
Total (times)13.46x6.93x

Compare with others

Compare: